カテゴリ： MarketLine, アメリカ, 企業調査

AbbVie Inc.：企業の戦略・SWOT・財務情報

◆英語タイトル：AbbVie Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15235
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：67
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

AbbVie Inc. – Strategy, SWOT and Corporate Finance Report
Summary

AbbVie Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AbbVie Inc. (AbbVie or ‘the company’) is a biopharmaceutical company. The company offers pharmaceutical products that mainly consist of Humira (adalimumab) and products in therapeutic areas of oncology, metabolics/hormone, endocrinology, and virology. It offers products for people of every stage across infant, adolescent, adult and senior. The company also provides patient support programs and partners with biotechs, government organizations, and universities. AbbVie has manufacturing facilities in Ireland, the US, China, Singapore, Germany and in Italy. It also operates R&D centers in Germany, the US and Japan. The company operates in the US, Canada, Mexico, European Union, Japan, Brazil and other countries. The company is headquartered in North Chicago, Illinois, the US.

Scope

- Detailed information on AbbVie Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis
- An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments
- Intelligence on AbbVie Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AbbVie Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AbbVie Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AbbVie Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AbbVie Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
AbbVie Inc.: Company Overview
AbbVie Inc.: Overview and Key Facts
AbbVie Inc.: Overview
AbbVie Inc.: Key Facts
AbbVie Inc.: Key Employees
AbbVie Inc.: Key Employee Biographies
AbbVie Inc.: Major Products and Services
AbbVie Inc.: Company History
AbbVie Inc.: Management Statement
AbbVie Inc.: Locations and Subsidiaries
AbbVie Inc.: Key Competitors
AbbVie Inc.: Company Analysis
AbbVie Inc.: Business Description
AbbVie Inc.: SWOT Analysis
AbbVie Inc.: SWOT Overview
AbbVie Inc.: Strengths
AbbVie Inc.: Weaknesses
AbbVie Inc.: Opportunities
AbbVie Inc.: Threats
AbbVie Inc.: Corporate Financial Deals Activity
AbbVie Inc.: Financial Deals Overview
AbbVie Inc.: Targets and Partners
AbbVie Inc.: Top Deals 2015 – 2019YTD*
AbbVie Inc.: Advisors
AbbVie Inc.: Top Legal Advisors
AbbVie Inc.: Top Financial Advisors
AbbVie Inc.: Mergers and Acquisitions
AbbVie Inc.: Corporate Venturing
AbbVie Inc.: Capital Raising
AbbVie Inc.: Partnership
AbbVie Inc.: Recent Developments
AbbVie Inc.: News and Events Summary
AbbVie Inc.: Business Expansion
AbbVie Inc.: Contracts
AbbVie Inc.: Financial Deals
AbbVie Inc.: Market Developments
AbbVie Inc.: Regulatory and Legal Events
AbbVie Inc.: Research & Development
AbbVie Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: AbbVie Inc.: Key Facts
Table 2: AbbVie Inc.: Key Employees
Table 3: AbbVie Inc.: Company History
Table 4: AbbVie Inc.: Locations and Subsidiaries
Table 5: AbbVie Inc.: Key Competitors
Table 6: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: AbbVie Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Table 9: AbbVie Inc.: Targets and Partners
Table 10: AbbVie Inc.: Top Deals 2015 - 2019YTD*
Table 11: AbbVie Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: AbbVie Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: AbbVie Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: AbbVie Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: AbbVie Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: AbbVie Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 18: AbbVie Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 19: AbbVie Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 20: AbbVie Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 21: AbbVie Inc.: News and Events Summary
Table 22: AbbVie Inc.: Business Expansion
Table 23: AbbVie Inc.: Contracts
Table 24: AbbVie Inc.: Financial Deals
Table 25: AbbVie Inc.: Market Developments
Table 26: AbbVie Inc.: Regulatory and Legal Events
Table 27: AbbVie Inc.: Research & Development
Table 28: AbbVie Inc.: Strategy and Operations

List of Figures
Figure 1: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AbbVie Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: AbbVie Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: AbbVie Inc.: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: AbbVie Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 8: AbbVie Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 9: AbbVie Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 10: AbbVie Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 11: AbbVie Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[AbbVie Inc.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sligro Food Group N.V.：戦略・SWOT・企業財務分析
    Sligro Food Group N.V. - Strategy, SWOT and Corporate Finance Report Summary Sligro Food Group N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Putnam Investments LLC：企業の戦略的SWOT分析
    Putnam Investments LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • BearingPoint：企業の戦略的SWOT分析
    BearingPoint - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • VGI Global Media Public Co Ltd：企業の戦略・SWOT・財務情報
    VGI Global Media Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary VGI Global Media Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hays plc：企業の戦略・SWOT・財務情報
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Orbis Biosciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, bunine …
  • TetraLogic Pharmaceuticals (TLOG)-製薬・医療分野：企業M&A・提携分析
    Summary TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therape …
  • Sumitomo Realty & Development Co., Ltd.
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Adverum Biotechnologies Inc (ADVM)：企業の財務・戦略的SWOT分析
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • Chiba University：製薬・医療：M&Aディール及び事業提携情報
    Summary Chiba University (Chiba) is an educational university that offers undergraduate education, short-term study program, graduation, double degree program, global COE program, good practice program, distinctive education and research, and international collaborative research program. The univers …
  • DesignMedix Inc-製薬・医療分野：企業M&A・提携分析
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases including malaria and diarrhea. The company focuses on the development of malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. Its malaria cure drugs …
  • Cannabics Pharmaceuticals Inc (CNBX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated cellular imaging and analysis platform designed …
  • Global Dominion Access SA：企業の戦略・SWOT・財務分析
    Global Dominion Access SA - Strategy, SWOT and Corporate Finance Report Summary Global Dominion Access SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Westinghouse Air Brake Technologies Corporation：企業の戦略・SWOT・財務情報
    Westinghouse Air Brake Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Westinghouse Air Brake Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Smith & Williamson Holdings Ltd：企業の戦略的SWOT分析
    Smith & Williamson Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Martinrea International Inc：企業の戦略・SWOT・財務情報
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Albany Molecular Research Inc-製薬・医療分野：企業M&A・提携分析
    Summary Albany Molecular Research Inc (AMRI) is a contract research and manufacturing organization. Its service portfolio drug discovery and development, manufacturing of Active Pharmaceutical Ingredients (API); process scale up development of fine chemicals and aseptic filling services for preclini …
  • Landeskreditbank Baden-Wuerttemberg-Foerderbank：企業の戦略・SWOT・財務分析
    Landeskreditbank Baden-Wuerttemberg-Foerderbank - Strategy, SWOT and Corporate Finance Report Summary Landeskreditbank Baden-Wuerttemberg-Foerderbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Urban One Inc (UONEK)：企業の財務・戦略的SWOT分析
    Urban One Inc (UONEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Puretech Health plc (PRTC)：企業の財務・戦略的SWOT分析
    Summary Puretech Health plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug ca …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆